Value Sense
HUM
Humana Inc. (HUM)
Last Price$261.5(3.3%)
Market Cap$31.5B
P/E LTM
22.5x
5Y avg
18.9x
Medical - Healthcare Plans industry median
15.2x
Stock quality & Intrinsic value
6/10
2.1% undervalued
HUM
is 205.0% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Humana Inc. P/E LTM

Annual
Quarterly
Daily
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
P/E LTM
30.8x
23.0x
17.1x
8.8x
7.7x
7.3x
10.8x
8.7x
11.0x
22.8x
20.2x
27.3x
18.8x
25.5x
19.1x
12.9x
22.4x
22.9x
18.6x
22.5x
HUM
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for HUM and see if it's the right time to invest.
Dive in

Humana Inc. (HUM) P/E LTM comparison analysis

General

LTM P/E LTM

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Humana Inc. logo
Humana Inc.HUM
26.1x
10.7%
(50.1%)
1.0%
Median Peer Set
15.2x
8.4%
(4.8%)
2.0%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
145.6x
56.5%
N/A
0.3%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
30.3x
8.9%
(35.7%)
3.6%
Cigna Corporation logo
Cigna CorporationCI
25.4x
8.4%
(18.9%)
2.6%
CVS Health Corporation logo
CVS Health CorporationCVS
17.8x
4.2%
(43.6%)
1.2%
Elevance Health Inc. logo
Elevance Health Inc.ELV
15.2x
3.2%
(0.0%)
3.4%
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
14.7x
19.3%
9.2%
2.9%
Centene Corporation logo
Centene CorporationCNC
8.8x
5.9%
27.4%
2.0%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
(24.3x)
27.2%
(4.8%)
(8.1%)
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
(43.5x)
(41.5%)
(31.3%)
(10.5%)

HUM key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
14,418.1
10.0%
21,416.5
48.5%
25,290.0
18.1%
28,946.4
14.5%
30,960.4
7.0%
33,868.2
9.4%
36,832.0
8.8%
39,126.0
6.2%
41,313.0
5.6%
48,500.0
17.4%
54,289.0
11.9%
54,379.0
0.2%
53,767.0
(1.1%)
56,912.0
5.8%
64,888.0
14.0%
77,155.0
18.9%
83,064.0
7.7%
92,870.0
11.8%
106,374.0
14.5%
117,761.0
10.7%
Cost of Goods Sold (COGS)0.00.00.00.00.00.05,395.05,830.06,355.07,639.07,318.07,277.06,567.07,525.07,381.010,052.010,121.012,671.013,188.00.0
Gross Profit
% margin
14,418.1
100.0%
21,416.5
100.0%
25,290.0
100.0%
28,946.4
100.0%
30,960.4
100.0%
33,868.2
100.0%
31,437.0
85.4%
33,296.0
85.1%
34,958.0
84.6%
40,861.0
84.2%
46,971.0
86.5%
47,102.0
86.6%
47,200.0
87.8%
49,387.0
86.8%
57,507.0
88.6%
67,103.0
87.0%
72,943.0
87.8%
80,199.0
86.4%
93,186.0
87.6%
117,761.0
100.0%
Operating Expenses13,976.020,591.023,932.027,873.029,035.031,742.034,488.037,110.039,252.046,138.051,672.052,638.049,505.054,620.061,176.072,198.079,319.089,070.0102,361.0115,199.0
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)2,176.83,021.53,476.53,944.74,227.54,662.85,395.05,830.06,355.07,639.07,295.07,173.06,419.07,525.07,381.010,052.010,121.012,198.00.00.0
Operating Income
% margin
421.7
2.9%
762.1
3.6%
1,289.3
5.1%
992.8
3.4%
1,601.8
5.2%
1,749.6
5.2%
2,235.0
6.1%
2,016.0
5.2%
2,061.0
5.0%
2,362.0
4.9%
2,617.0
4.8%
1,741.0
3.2%
4,262.0
7.9%
2,292.0
4.0%
3,712.0
5.7%
4,957.0
6.4%
3,745.0
4.5%
3,800.0
4.1%
4,013.0
3.8%
2,562.0
2.2%
Interest Income0.00.00.00.00.00.10.0105.0140.0192.0186.0189.0242.0218.0242.0283.0326.0401.00.00.0
Interest Expense39.363.168.980.3105.8105.1109.0105.0140.0192.0186.0189.0242.0218.0242.0283.0326.0401.0493.0660.0
Pre-tax Income421.7762.11,289.3992.81,601.81,749.62,235.01,911.01,921.02,170.02,431.01,552.04,020.02,063.03,456.04,600.03,354.03,568.03,383.01,721.0
Income Tax
% effective tax rate
113.2
26.9%
274.7
36.0%
455.6
35.3%
345.7
34.8%
562.1
35.1%
650.2
37.2%
816.0
36.5%
689.0
36.1%
690.0
35.9%
1,023.0
47.1%
1,155.0
47.5%
938.0
60.4%
1,572.0
39.1%
391.0
19.0%
763.0
22.1%
1,307.0
28.4%
485.0
14.5%
762.0
21.4%
836.0
24.7%
413.0
24.0%
Net Income
% margin
308.5
2.1%
487.4
2.3%
833.7
3.3%
647.2
2.2%
1,039.7
3.4%
1,099.4
3.2%
1,419.0
3.9%
1,222.0
3.1%
1,231.0
3.0%
1,147.0
2.4%
1,276.0
2.4%
614.0
1.1%
2,448.0
4.6%
1,683.0
3.0%
2,707.0
4.2%
3,367.0
4.4%
2,933.0
3.5%
2,806.0
3.0%
2,489.0
2.3%
1,207.0
1.0%
EPS1.912.975.003.876.216.558.587.567.817.448.544.1116.9412.2420.2025.4722.7922.2020.0910.02
Diluted EPS1.872.904.913.836.156.478.467.477.737.368.444.0716.8112.1620.1025.3122.6722.0820.009.99
EBITDA
% margin
550.6
3.8%
910.7
4.3%
1,474.1
5.8%
1,293.5
4.5%
1,852.0
6.0%
2,117.5
6.3%
2,538.0
6.9%
2,354.0
6.0%
2,487.0
6.0%
2,811.0
5.8%
3,064.0
5.6%
2,206.0
4.1%
4,747.0
8.8%
2,848.0
5.0%
4,170.0
6.4%
5,446.0
7.1%
4,340.0
5.2%
4,678.0
5.0%
4,930.0
4.6%
3,119.0
2.6%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Humana Inc.'s P/E LTM?

As of today, Microsoft Corp's last 12-month P/E LTM is 22.5x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/E LTM for Humana Inc. have been 20.0x over the past three years, and 19.9x over the past five years.

2) Is Humana Inc.'s P/E LTM Good?

As of today, Humana Inc.'s P/E LTM is 22.5x, which is higher than industry median of 15.2x. It indicates that Humana Inc.'s P/E LTM is Bad.

3) How does Humana Inc.'s P/E LTM compare to its peers?

As of today, Humana Inc.'s P/E LTM is 22.5x, which is higher than peer median of 15.2x. The list of peers includes OSCR, UNH, CI, CVS, ELV, MOH, CNC, ALHC, CLOV.